SCHEMBL7645784

SCHEMBL7645784

CP(=O)(O)CCCNc1ccc(Cl)cc1Cl

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.48
CA14 Q9ULX7 1/20 0.48
MPI P34949 1/20 0.42
LMNA P02545 3/20 0.42
GGPS1 O95749 1/20 0.41
SMN1; SMN2 Q16637 3/20 0.40
MRGPRX4 Q96LA9 1/20 0.40
USP2 O75604 1/20 0.40
HPGD P15428 1/20 0.40
L3MBTL1 Q9Y468 2/20 0.39
POLB P06746 1/20 0.39
THRB P10828 1/20 0.39
RECQL P46063 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
GAA P10253 1/20 0.39
MEN1 O00255 2/20 0.38
MAPT P10636 2/20 0.38
KMT2A Q03164 2/20 0.38
PKM P14618 1/20 0.38
HTT P42858 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7645193 0.89 CA1 (0.39) CA1CA14MPILMNAGGPS1
SCHEMBL7645204 0.78 RHOC (0.45) CA14LMNASMN1; SMN2GAAMEN1
SCHEMBL7648081 0.77 EPHX1 (0.44) LMNASMN1; SMN2HPGDL3MBTL1GAA
SCHEMBL7646938 0.75 RHOC (0.41) LMNAL3MBTL1GAAMEN1MAPT
SCHEMBL7646145 0.75 MMP8 (0.46) CA14SMN1; SMN2L3MBTL1MEN1MAPT
SCHEMBL7790487 0.74 MPI (0.44) MPILMNASMN1; SMN2MRGPRX4HPGD
SCHEMBL7646266 0.74 S1PR1 (0.37) CA14LMNAL3MBTL1THRBGAA
SCHEMBL10396655 0.72 LMNA (0.46) CA1CA14LMNASMN1; SMN2MRGPRX4
SCHEMBL7531364 0.72 LMNA (0.58) CA1CA14LMNASMN1; SMN2MRGPRX4
SCHEMBL7645786 0.72 MPI (0.43) CA1CA14MPILMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002100871-A1 NEW COMPOUNDS USEFUL IN REFLUX DISEASE ASTRAZENECA AB (SE) 2002-12-19 WO claimed